Featured Content

Developing Nonviral Gene Therapy for Hemophilia A
CGTLive | January 9, 2023

Takeda’s Poseida Partnership Starts to Pay Off with Promising Hemophilia A Gene Therapy Data
Fierce Biotech | December 14, 2022

The Top Line
Fierce Biotech | November 11, 2022
Press Releases
Poseida in the News
Devon J. Shedlock, PhD, on Shifting from Autologous to Allogeneic Therapies
CGT Live | October 14, 2022
CRISPR-Cas9 Alternatives: Cutting through the Boundaries of Gene Editing
Genetic Engineering & Biotechnology News | August 24, 2022
CAR-T Cell Therapies for Hematologic Malignancies the Focus of New Poseida, Roche Collaboration
CGT Live | August 8, 2022
Roche Dives Deeper into Off-The-Shelf Cell Therapies in Poseida Partnership
Gene Online | August 4, 2022
Roche wades deeper into the allogeneic CAR-T field, reserving billions for its next early-stage partner
Endpoints News | August 3, 2022